Association Between Pericoronary Fat Attenuation Index as Evaluated by Coronary Artery CT Angiography and Clinical Interventions in Lipid Management Among Patients with Coronary Artery Disease
Yu-Sen Feng,Zheng-Yun Sun,Fei Jiang,Peng-Cheng Ma,Xing-Rui Liu,Yuan-Yuan Meng,Cheng-De Liao,Gui-Fang Sun
DOI: https://doi.org/10.2147/ijgm.s468768
IF: 2.145
2024-10-26
International Journal of General Medicine
Abstract:Yu-Sen Feng, 1, &ast Zheng-Yun Sun, 2, &ast Fei Jiang, 3 Peng-Cheng Ma, 1 Xing-Rui Liu, 1 Yuan-Yuan Meng, 2 Cheng-De Liao, 1 Gui-Fang Sun 1 1 Department of Radiology, Kunming Yan'an Hospital, Kunming, 650051, People's Republic of China; 2 Department of Radiology, Lincang First People's Hospital, Lincang, 677000, People's Republic of China; 3 Department of Radiology, Wenshan First People's Hospital, Wenshan, 663599, People's Republic of China &astThese authors contributed equally to this work Correspondence: Gui-Fang Sun, Department of Radiology, Kunming Yan'an Hospital, No. 245 Renmin East Road, Panlong District, Kunming, Yunnan, 650051, People's Republic of China, Tel +86 13759518529, Email Objective: This study aims to evaluate the relationship between the pericoronary fat attenuation index (FAI), derived from coronary artery computed tomography angiography, and post-lipid management levels of low-density lipoprotein cholesterol in patients with coronary artery disease (CAD). Additionally, the study investigates coronary inflammation across different lipid management strategies. Methods: We selected a cohort comprising 521 CAD patients who met the inclusion criteria. Patients were categorized into well-managed (LDL-C< 2.6 mmol/L) and poorly managed (LDL-C≥ 2.6 mmol/L) groups based on lipid management efficacy. We collected anthropometric measures (height, weight, body mass index, and body surface area) and clinical indicators, including Gensini score, and FAI-related parameters for coronary atherosclerotic lesions. We analyzed the interrelations along these parameters and lipid management using statistical methods and assessed diagnostic value via receiver operating characteristic (ROC) curve analysis of these parameters was assessed through. Results: The poorly managed group exhibited significantly higher levels of total cholesterol, triglycerides, and lower levels of high-density lipoprotein compared to the well-managed group (P < 0.05). Significant differences were observed between the groups in terms of lesion length in the proximal segment of the left anterior descending artery, FAI value in the proximal segment of lesions in the right coronary artery (RCA), volume thickness in the middle segment of RCA lesions, and lesion length in the distal segment of RCA (P < 0.05). ROC curve analysis revealed areas under the curve ranging from 0.484 to 0.660 for the parameters, indicating limited diagnostic efficacy. Conclusion: The FAI in the RCA varies with lipid management strategies, suggesting it as a valuable metric for monitoring both perivascular inflammation and lipid status in CAD patients. However, its current diagnostic efficacy is limited, indicating the need for further research to improve its clinical utility. Keywords: coronary artery CT angiography, coronary atherosclerotic heart disease, coronary inflammation, lipids, low-density lipoprotein cholesterol, pericoronary fat attenuation index Coronary artery disease (CAD) represents a prevalent cardiovascular condition. In urban China, CAD exhibits a mortality rate of 126.91 per 100,000, a concerning trend marked by escalating prevalence and mortality rates, thereby posing substantial health hazards. 1 Low-density lipoprotein cholesterol (LDL-C) is a pathogenic risk factor and primary target for intervention in CAD. The mechanism of action of cLDL in coronary heart disease is that the antioxidant content of small and dense low-density lipoprotein in cLDL is low, which is very easy to oxidize, difficult to clear from plasma, and easy to adhere to the vascular wall. 2 It has been confirmed that it can be used as an independent risk factor for predicting atherosclerosis, and has been included in the National Cholesterol Education Plan of the United States. 3 However, the treatment rate for LDL-C among patients at high risk of atherosclerotic cardiovascular disease (ASCVD) in China stands at a modest 42.9%. 4 While lipid-lowering therapies have demonstrated efficacy in slowing and even reversing the progression of coronary atherosclerosis, apprehensions about safety emerge when LDL-C levels are excessively low, potentially resulting in intracranial hemorrhage. 5,6 Pericoronary inflammation (referred to as coronary inflammation) plays a key role in different stages of the development of coronary atherosclerotic plaque, affecting the formation and stability of plaque. 7,8 Severe inflammation can easily cause significant vascular stenosis and unstable plaques, leading to adverse events. Consequently, there is a critical need to assess the inflammatory s -Abstract Truncated-
medicine, general & internal